信雅達(600571.SH):擎川投資擬引進三位新合夥人 基金規模增至1.4億元
格隆匯11月29日丨信雅達(600571.SH)公佈,公司以有限合夥人身份(LP)出資3000萬元人民幣入股西安擎川創業投資合夥企業(有限合夥)(“擎川投資”),擎川投資的普通合夥人及管理人為上海融璽創業投資管理有限公司(“融璽投資”)。
公司於近日接到擎川投資管理人融璽投資的通知,擎川投資擬引進三位新合夥人,基金規模由1億元人民幣增至1.4億元人民幣,引進的三位新合夥人與公司不存在關聯關係。
引進三位新合夥人後,擎川投資基金規模及資金結構如下:

截至公告日,公司已出資2100萬元人民幣,擎川投資此次變更尚在工商審核階段。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.